Filtros de búsqueda

Lista de obras de Catherine S.M. Diefenbach

Advances in Therapy for Relapsed or Refractory Hodgkin Lymphoma

scientific article published on 24 January 2020

An evaluation of brentuximab vedotin as a treatment option for stage III/IV Hodgkin lymphoma

scientific article published on 05 September 2019

Author Correction: The bone marrow microenvironment at single-cell resolution

artículo científico publicado en 2019

Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry

artículo científico publicado en 2016

CART19 in Hodgkin lymphoma: are we driving the right model?

artículo científico publicado en 2018

Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy

artículo científico publicado en 2020

Checkpoint Inhibition in Hodgkin Lymphoma: Saving the Best for Last?

artículo científico publicado en 2016

Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy

scientific article published on 19 May 2020

Development of highly aggressive mantle cell lymphoma after sofosbuvir treatment of hepatitis C.

artículo científico publicado en 2016

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma.

artículo científico publicado en 2011

Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era

artículo científico publicado en 2015

Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.

artículo científico publicado en 2016

Hodgkin lymphoma: targeting the tumor microenvironment as a therapeutic strategy

artículo científico

Immune targeting of the microenvironment in classical Hodgkin's lymphoma: insights for the hematologist

scientific article published on 03 May 2019

Immunity War: A Novel Therapy for Lymphoma Using T-cell Bispecific Antibodies

artículo científico publicado en 2018

Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma

artículo científico publicado en 2020

Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival

scientific article published on 01 October 2006

Mantle cell lymphoma in relapse: the role of emerging new drugs.

scientific article published on September 2010

Microbial dysbiosis is associated with aggressive histology and adverse clinical outcome in B-cell non-Hodgkin lymphoma

Misdiagnosis of non-hodgkin lymphoma as multiple myeloma

artículo científico publicado en 2012

Monomorphic T-cell post-transplant lymphoproliferative disorders exhibit markedly inferior outcomes compared to monomorphic B-cell post-transplant lymphoproliferative disorders

scientific article published on 01 September 2010

New Treatment Algorithms in Hodgkin Lymphoma: Too Much or Too Little?

artículo científico publicado en 2018

New strategies in Hodgkin lymphoma: better risk profiling and novel treatments.

artículo científico

New therapeutic targets and drugs in non-Hodgkinʼs lymphoma ⬇️

artículo científico publicado el 1 de julio de 2011

Peripheral T-cell lymphoma: time for a T-cell-centric standard of care

artículo científico publicado en 2013

Phase 1 study of the PI3Kδ inhibitor INCB040093 ± JAK1 inhibitor itacitinib in relapsed/refractory B-cell lymphoma

artículo científico publicado en 2018

Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or Lymphoma

artículo científico publicado en 2015

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)

scientific article published on 29 March 2019

Potentially inappropriate medication use in elderly non-Hodgkin lymphoma patients is associated with reduced survival and increased toxicities.

artículo científico publicado en 2017

Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer

article

Relapsed Hodgkin lymphoma: management strategies

artículo científico publicado en 2014

Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphoma.

artículo científico publicado en 2017

Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.

artículo científico publicado en 2008

Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era

scientific article published on 07 January 2019

Targeting CD30 in hodgkin lymphoma: antibody-drug conjugates make a difference

artículo científico publicado en 2012

The bone marrow microenvironment at single-cell resolution

scientific article published on 10 April 2019

XII. Hodgkin lymphoma in older patients: challenges and opportunities to improve outcomes.

artículo científico

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda